GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Levitee Labs Inc (XCNQ:LVT) » Definitions » FCF Margin %

Levitee Labs (XCNQ:LVT) FCF Margin % : 3.32% (As of Jun. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Levitee Labs FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Levitee Labs's Free Cash Flow for the three months ended in Jun. 2022 was C$0.10 Mil. Levitee Labs's Revenue for the three months ended in Jun. 2022 was C$2.93 Mil. Therefore, Levitee Labs's FCF Margin % for the quarter that ended in Jun. 2022 was 3.32%.

As of today, Levitee Labs's current FCF Yield % is 0.00%.

The historical rank and industry rank for Levitee Labs's FCF Margin % or its related term are showing as below:

XCNQ:LVT' s FCF Margin % Range Over the Past 10 Years
Min: -106.65   Med: 0   Max: 0
Current: -106.65


XCNQ:LVT's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.265 vs XCNQ:LVT: -106.65


Levitee Labs FCF Margin % Historical Data

The historical data trend for Levitee Labs's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Levitee Labs FCF Margin % Chart

Levitee Labs Annual Data
Trend Sep20 Sep21
FCF Margin %
- -358.11

Levitee Labs Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
FCF Margin % Get a 7-Day Free Trial Premium Member Only - -258.16 -120.29 -139.53 3.32

Competitive Comparison of Levitee Labs's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Levitee Labs's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Levitee Labs's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Levitee Labs's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Levitee Labs's FCF Margin % falls into.



Levitee Labs FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Levitee Labs's FCF Margin for the fiscal year that ended in Sep. 2021 is calculated as

FCF Margin=Free Cash Flow (A: Sep. 2021 )/Revenue (A: Sep. 2021 )
=-6.163/1.721
=-358.11 %

Levitee Labs's FCF Margin for the quarter that ended in Jun. 2022 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2022 )/Revenue (Q: Jun. 2022 )
=0.097/2.925
=3.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Levitee Labs FCF Margin % Related Terms

Thank you for viewing the detailed overview of Levitee Labs's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Levitee Labs (XCNQ:LVT) Business Description

Traded in Other Exchanges
N/A
Address
800 West Pender Street, Suite 215, Vancouver, CAN, V6C 2V6
Levitee Labs Inc is a functional mushrooms company, focused on the development and sale of high potency mushroom extract nutraceuticals and supplies and equipment for mushroom cultivation. The company believes, based on a growing body of research, that mushrooms can be an effective way to enhance wellbeing and potentially treat various kinds of mental and physical health problems. The medical services segment is engaged in providing medical treatment. The selling products segment is into buying and selling products Substantial revenue is generated from medical services operations.
Executives
Pouya Farmand Director, Senior Officer
Maisam Darabi Senior Officer
Mackenzie Osborne Director

Levitee Labs (XCNQ:LVT) Headlines

No Headlines